GANX - Gain Therapeutics GAAP EPS of -$0.62 August, 10 2023 10:31 AM Gain Therapeutics Inc. 2023-08-10 10:31:02 ET Gain Therapeutics press release ( NASDAQ: GANX ): Q2 GAAP EPS of -$0.62. Cash, cash equivalents and marketable securities were $16.2 million as of June 30, 2023, For further details see: Gain Therapeutics GAAP EPS of -$0.62